Simple, Elegant Solutions for
Complex Clinical Challenges
PrimeraDx’s innovative clinical platform, the ICEPlex System, represents the next generation of quantitative PCR. ICEPlex combines two established technologies—PCR® and capillary electrophoresis—to deliver highly multiplexed, quantitative clinical solutions.
Our clinical research customers can use the ICEPlex System as an open platform and immediately put it to work in their labs. And our pharmaceutical partners can collaborate with us to develop high-value companion diagnostic products.
With the ICEPlex System, our customers can easily design very complex multi-modal assays that test for disparate target types like SNPs, expression biomarkers, miRNAs and fusion genes.
PrimeraDx’s technology is the next generation of quantitative PCR. Put the power of the ICEPlex System to work for you. Contact us. Learn more about the ICEPlex System.
The ICEPlex System is a registered trademark. PCR® is a registered trademark of Roche Molecular Systems Inc.
News
PrimeraDx Featured in the Goldman Sachs Healthcare Research Team’s GS Emerging Healthcare Series. PrimeraDx, Inc. was highlighted in a conference call with the Goldman Sachs Healthcare Research Team as part of the GS Emerging Healthcare Series on M… MORE
Events
American Society of Hematology (ASH) Annual Meeting
New Orleans, LA
December 7–9, 2014
